Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bratland, A.
Right arrow Articles by Ree, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bratland, A.
Right arrow Articles by Ree, A. H.
[Cancer Research 60, 5578-5583, October 1, 2000]
© 2000 American Association for Cancer Research

Tumor Biology

Expression of a Novel Factor, com1, Is Regulated by 1,25-Dihydroxyvitamin D3 in Breast Cancer Cells1

Åse Bratland, Karianne Risberg, Gunhild M. Mælandsmo, Kristine Bjerve Gützkow, Øyvind E. Olsen, Amir Moghaddam, Meng-yu Wang, Christina Mørk Hansen, Heidi Kiil Blomhoff, Jens P. Berg, Øystein Fodstad and Anne Hansen Ree2

Departments of Tumor Biology [Å. B., K. R., G. M. M., Ø. E. O., A. M., M-y. W., Ø. F., A. H. R.] and Oncology [A. H. R.], The Norwegian Radium Hospital, 0310 Oslo, Norway; University of Oslo, Institute of Medical Biochemistry, 0317 Oslo, Norway [K. B. G., H. K. B.]; Aker University Hospital, Hormone Laboratory, 0514 Oslo, Norway [J. P. B.]; and Leo Pharmaceutical Products, 2750 Ballerup, Denmark [C. M. H.]

Tumor cells and their surrounding microenvironment produce a variety of factors that promote tumor growth and metastasis. We recently identified a nuclear factor, termed com1, that is up-regulated in human breast carcinoma cells on formation of experimental metastatic tumors and is assumed to act as a growth-promoting factor in breast cancer. 1,25-Dihydroxyvitamin D3 [1,25(OH)2D3] is a potent inhibitor of growth in breast cancer both in vitro and in vivo. We compared the growth-regulatory mechanisms of nontumorigenic and estrogen-dependent MCF-7 cells with those of the tumorigenic and tamoxifen-resistant subline MCF7/LCC2 in the presence of 1,25(OH)2D3. Proliferation of MCF7/LCC2 cells, which revealed constitutive com1 expression, was inhibited by 1,25(OH)2D3 (10-7 M). This was strongly associated with cell cycle arrest in G1 phase, consistent with accumulation of the hypophosphorylated form of the retinoblastoma protein as well as the induction of the cyclin-dependent kinase inhibitor p21. These cell cycle events were preceded by a transient up-regulation (5–8-fold) of com1 mRNA. Furthermore, clonal growth of the MCF7/LCC2 cells was also inhibited by 1,25(OH)2D3 (10-7 M), and when the com1-negative MCF-7 cells were stably transfected with com1, the resulting MCF7/com1 cells showed a significant decrease in colony formation. These results seem to indicate that rather than promoting growth, com1 may participate in the regulatory pathway involved in cellular growth inhibition when recruited by inhibitory signals.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
M. Ishida, M. Miyamoto, S. Naitoh, D. Tatsuda, T. Hasegawa, T. Nemoto, H. Yokozeki, K. Nishioka, A. Matsukage, M. Ohki, et al.
The SYT-SSX Fusion Protein Down-Regulates the Cell Proliferation Regulator COM1 in t(x;18) Synovial Sarcoma
Mol. Cell. Biol., February 15, 2007; 27(4): 1348 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Path, A. Opel, M. Gehlen, V. Rothhammer, X. Niu, C. Limbert, L. Romfeld, S. Hugl, A. Knoll, M. D. Brendel, et al.
Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1168 - E1176.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Vasseur, E. Folch-Puy, V. Hlouschek, S. Garcia, F. Fiedler, M. M. Lerch, J. C. Dagorn, D. Closa, and J. L. Iovanna
p8 Improves Pancreatic Response to Acute Pancreatitis by Enhancing the Expression of the Anti-inflammatory Protein Pancreatitis-associated Protein I
J. Biol. Chem., February 20, 2004; 279(8): 7199 - 7207.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Path, A. Opel, A. Knoll, and J. Seufert
Nuclear Protein p8 Is Associated With Glucose-Induced Pancreatic {beta}-Cell Growth
Diabetes, February 1, 2004; 53(90001): S82 - 85.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. S. Coker and E. Davies
Correspondence re: A. H. Ree et al., Expression of a Novel Factor in Human Breast Cancer Cells with Metastatic Potential. Cancer Res., 59: 4675-4680, 1999
Cancer Res., July 15, 2002; 62(14): 4164 - 4165.
[Full Text] [PDF]

Home page
 FASEB J.Home page
F. TOSETTI, N. FERRARI, S. DE FLORA, and A. ALBINI
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
FASEB J, January 1, 2002; 16(1): 2 - 14.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.